Mipletamig-driven clinical validation of the CRIS-7 derived CD3-binding domain underpins Aptevo's expansion from hematologic to solid tumorsNew candidate APVO455 targets Nectin-4+ cancers, joins ...

National Statistician and Civil Registrar General Usec. Claire Dennis S. Mapa (2nd from left) leading the distribution of ...

Minor (under 18) without a Canadian parent applying alone. to send your application as soon as possible after you sign and date the application form We’ll return your application to you if we receive ...

Lyra Therapeutics has lost >90% of its value since announcing the failed ENLIGHTEN-1 trial. Click here to find out why I rate ...

CD19-CAR T-cell treatment is a novel option of deep B cell depletion with promising results across different rheumatologic ...